Skip to main content
CVE Vulnerability Database
Vulnerability Database/CVE-2026-68067

CVE-2026-68067: Mira Cloud API Auth Bypass Vulnerability

CVE-2026-68067 is an authentication bypass flaw in Mira Cloud API that allows attackers to gain unauthorized access using only an email address. This post covers technical details, affected systems, and mitigation.

Published:

CVE-2026-68067 Overview

CVE-2026-68067 is an authentication bypass vulnerability in the Mira cloud API login endpoint. The endpoint accepts any format-valid string in the password field and returns a live active session token for the account matching the supplied email address. An attacker who knows or guesses a user's email address can take full control of the associated cloud account without knowing the password.

The flaw allows unauthenticated attackers to access hormone record information, modify account settings, and impersonate legitimate users. The vulnerability is tracked under [CWE-1390: Weak Authentication] and was published in a CISA medical device advisory.

Critical Impact

An attacker with knowledge of a user's email address can obtain a valid session token and gain full access to protected health information and account controls without any valid credentials.

Affected Products

  • Mira cloud API (login endpoint)
  • Mira user accounts accessed through the cloud service
  • Hormone record data and account configuration stored in the Mira cloud

Discovery Timeline

  • 2026-08-11 - CVE-2026-68067 published to NVD
  • 2026-08-12 - Last updated in NVD database

Technical Details for CVE-2026-68067

Vulnerability Analysis

The Mira cloud API exposes a login endpoint that performs improper credential validation. When a client submits an authentication request, the service parses the supplied email address and password. The server confirms that the password field contains a syntactically valid string but never compares it against the stored credential material for the account.

After this superficial check, the endpoint issues a live, authenticated session token bound to the account that matches the supplied email address. That token behaves identically to a token issued after a legitimate login. It grants the attacker access to hormone tracking records, personal profile data, and account settings.

Because the flaw is a network-reachable authentication bypass, exploitation does not require prior access, user interaction, or elevated privileges. Any attacker who can reach the API and enumerate or guess an email address can compromise the corresponding account.

Root Cause

The root cause is a missing password verification step in the authentication handler. The endpoint treats format validation as proof of identity. This is a classic instance of [CWE-1390: Weak Authentication], where the authentication logic exists but does not enforce a meaningful secret check before issuing session material.

Attack Vector

Exploitation is straightforward. An attacker sends an HTTPS POST request to the Mira login endpoint with a target email address and any non-empty string as the password. The API responds with a valid bearer token. The attacker then reuses the token against downstream API endpoints to read hormone records, change email or notification settings, or lock legitimate users out. See the CISA Medical Advisory and the GitHub CSAF Document for the coordinated disclosure details.

Detection Methods for CVE-2026-68067

Indicators of Compromise

  • Authentication success events from the Mira cloud API for accounts that did not originate a login from a known device or IP address.
  • Session tokens issued in rapid succession for many distinct email addresses from a small pool of source IPs, indicating enumeration.
  • Account setting changes, email address updates, or bulk hormone record exports that were not initiated by the account owner.

Detection Strategies

  • Correlate API login events with historical geolocation and device fingerprint baselines to flag anomalous session issuance.
  • Alert on authentication requests where the password field contains obvious placeholder values or where the same source repeatedly logs in as different users.
  • Monitor API access logs for token reuse from IP ranges associated with known scanning infrastructure or anonymizing services.

Monitoring Recommendations

  • Enable verbose logging on all cloud API authentication endpoints, capturing source IP, User-Agent, email, and token identifier.
  • Forward authentication and account modification logs to a centralized SIEM for correlation and long-term retention.
  • Establish rate limiting and alerting thresholds on repeated login attempts against distinct accounts from a single source.

How to Mitigate CVE-2026-68067

Immediate Actions Required

  • Apply the vendor fix as soon as it is released by the Mira service operator. This is a server-side vulnerability that cannot be remediated by end users alone.
  • Invalidate all outstanding session tokens and require re-authentication once the patch is deployed.
  • Force password resets for all accounts and notify users of the potential exposure of hormone records and account settings.

Patch Information

Remediation must be performed by the Mira cloud service provider. Refer to the CISA Medical Advisory ICSMA-26-223-01 and the GitHub CSAF Document for authoritative fix status and vendor guidance. No customer-side patch exists because the vulnerability lives in the cloud API.

Workarounds

  • Restrict use of the Mira cloud service until the vendor confirms the login endpoint enforces password verification.
  • Where feasible, enable any available multi-factor authentication option on affected accounts to raise the cost of token abuse.
  • Review recent account activity for unauthorized setting changes or data exports and revoke sessions from unknown devices.

Disclaimer: This content was generated using AI. While we strive for accuracy, please verify critical information with official sources.

Default Legacy - Prefooter | Experience the World’s Most Advanced Cybersecurity Platform

Experience the Most Advanced Cybersecurity Platform

See how the world’s most intelligent, autonomous cybersecurity platform can protect your organization today and into the future.